|
Report Date : |
17.11.2014 |
IDENTIFICATION DETAILS
|
Name : |
CAPSUGEL DE MEXICO S DE RL DE CV |
|
|
|
|
Registered Office : |
Carretera Veracruz 1030 Colonia San Jose Maravillas 72225 Prolongacion
Diagonal Defensores Y Parque Industrial Puebla 2000 Camino A Resurreccion
Puebla |
|
|
|
|
Country : |
Mexico |
|
|
|
|
Year of Establishment : |
2007 |
|
|
|
|
Legal Form : |
Sociedad de Responsabilidad Limitada de Capital Variable |
|
|
|
|
Line of Business : |
Provider of Hard Capsules |
|
|
|
|
No. of Employees : |
70 |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 1, 2014
|
Country Name |
Previous Rating (31.03.2014) |
Current Rating (01.06.2014) |
|
Mexico |
A2 |
A2 |
|
Risk Category |
ECGC Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
MEXICO - ECONOMIC
OVERVIEW
Mexico's $1.3 trillion economy
has become increasingly oriented toward manufacturing in the 20 years since the
North American Free Trade Agreement (NAFTA) entered into force. Per capita
income is roughly one-third that of the US; income distribution remains highly
unequal. Mexico has become the United States' second-largest export market and
third-largest source of imports. In 2013, two-way merchandise trade reached
nearly $507 billion. Mexico has free trade agreements with over 50 countries
including Guatemala, Honduras, El Salvador, the European Free Trade Area, and
Japan - putting more than 90% of trade under free trade agreements. In 2012
Mexico formally joined the Trans-Pacific Partnership negotiations and formed
the Pacific Alliance with Peru, Colombia and Chile. Mexico's current
government, led by President Enrique PENA NIETO, emphasized economic reforms
during its first year in office, passing education, energy, financial, fiscal
and telecommunications reform legislation. The three-party "Pact for
Mexico" reform agenda aims to improve competitiveness and economic growth
across the Mexican economy.
|
Source
: CIA |
company Name and address
|
|
|
Name |
Capsugel
De Mexico S De Rl De CV |
|
Address in the
order: |
NA |
|
Legal Name: |
CAPSUGEL
DE MEXICO S. R.L. DE C.V. |
|
Trade Name: |
CAPSUGEL
DE MEXICO |
|
RFC: |
CME061103KG5 |
|
Date Created: |
1931 |
|
Date
Incorporated: |
2007 |
|
Legal Address: |
CARRETERA
VERACRUZ 1030 COLONIA SAN JOSE MARAVILLAS 72225 PROLONGACION DIAGONAL DEFENSORES
Y PARQUE INDUSTRIAL PUEBLA 2000 CAMINO A RESURRECCION PUEBLA, MEXICO |
|
Operative
Address: |
Insurgentes Sur
No. 826, Piso 11 Sur |
|
Telephone: |
(55) 5543-2787 |
|
Fax: |
(55) 5543-2787 |
|
Legal Form: |
Sociedad de
Responsabilidad Limitada de Capital Variable |
|
Email: |
|
|
Registered in: |
142: CAMARA
NACIONAL DE LA INDUSTRIA DE TRANSFORMACION / Mexico |
|
Website: |
|
|
Manager: |
Teresa Rodriguez |
|
Staff: |
70 |
|
Activity: |
Provider of hard
capsules |
|
SIC Codes: |
5162 5169 |
|
NAICS Codes: |
424610 424690 |
BANKS
|
|
|
BANK |
BANCO
SANTANDER |
|
The
company does not publish its banking information. |
|
HISTORY
|
|
|
The
company was incorporated in 2007. |
|
|
Capugel
was founded in 1931 in Detroit, Michigan as a division of Parke-Davis, after
Arthur Colton designed a machine which simultaneously manufactured the body
and caps of a hard gelatin capsule, and fit them together. In 1970,
Parke-Davis, including Capsugel, was acquired by Warner Lambert, which was
acquired by Pfizer in 2000. On 1 August 2011, Pfizer sold Capsugel to global
investment firm Kohlberg Kravis Roberts for $2.38 billion. |
|
MAIN ACTIVITY
|
|
|
Capsugel is the world’s
leading provider of hard capsules and an innovator in drug delivery systems
for the pharmaceutical, OTC and health and nutrition industries. |
|
|
Products/Services:
|
It
offers a comprehensive array of products and services, from hard gelatin,
vegetarian and liquid-filled capsules, to innovative R&D equipment and
liquid formulations as part of its Licaps Drug Delivery System. |
|
Brands: |
Coni-Snap
®, Vcaps® y Vcaps®Plus, DRcaps™, Press-fit® y
Xpress-fit™, Licaps®,
Plantcaps™, DBcaps®, Ocean Caps™. |
|
Competitors: |
SINTETIC
MEXICANA |
|
Sales: |
Wholesale |
|
Clients: |
Capsugel
Brasil Importacao |
|
Suppliers |
P.
B. GELATINS UK LTD |
|
Operations
Area: |
National
& International |
|
The
company imports from |
UK,
France, Hong Kong, Taiwan |
|
The company
exports to |
Colombia,
Brazil, Belgium |
|
The
company employs |
71
employees |
|
Payments: |
Regular-made
on a 45 day basis |
LOCATION
|
|
|
Headquarters : |
Insurgentes Sur
No. 826, Piso 11 Sur |
|
Branches:
|
Av.
18 de Noviembre 1030-A Puebla, Pue.
72290, Mexico |
|
Business
Industry: |
Companies
in this industry manufacture and process pharmaceutical products. |
GROUP
STRUCTURE AND SUBSIDIARY COMPANIES
|
|
|
Listed at the
stock exchange: |
NO |
|
Capital: |
NA |
|
Shareholders %: |
Capsugel
de Mexico, S. de R.L. de C.V. operates as a subsidiary of: |
|
Management: |
Mr. Guido
Edouard Driesen, Regional President |
|
Related
Companies: |
Capsugel
has research and development labs in: |
FINANCIAL INFORMATION
|
|
|
This
is a private company which does not make its financial public. The following
information was provided by outside sources. |
|
|
2013
USD |
|
|
Turnover |
53
000 000 |
|
Net
Income |
1
800 000 |
|
Net
Worth |
4
000 000 |
|
Liabilities |
500
000 |
|
Cash
Flow |
Good |
|
Capsugel,
Inc (USA) |
2013 |
|
Revenue |
USD
880 000 000 |
|
Kohlberg
Kravis Roberts & Co. L.P. (KKR) |
2013
All numbers in thousands |
|
Total
Revenue |
662,93 |
|
Cost
of Revenue |
- |
|
Gross
Profit |
662,93 |
|
Operating
Expenses |
|
|
Research
Development |
- |
|
Selling
General and Administrative |
1,767,138 |
|
Non
Recurring |
- |
|
Others |
- |
|
Total
Operating Expenses |
- |
|
Operating
Income or Loss |
(1,104,208) |
|
Income
from Continuing Operations |
|
|
Total
Other Income/Expenses Net |
8,996,362 |
|
Earnings
Before Interest And Taxes |
7,991,770 |
|
Interest
Expense |
99,616 |
|
Income
Before Tax |
7,892,154 |
|
Income
Tax Expense |
37,926 |
|
Minority
Interest |
(7,163,002) |
|
Net
Income From Continuing Ops |
691,226 |
|
Non-recurring
Events |
|
|
Discontinued
Operations |
- |
|
Extraordinary
Items |
- |
|
Effect
Of Accounting Changes |
- |
|
Other
Items |
- |
|
Net
Income |
691,226 |
|
Preferred
Stock And Other Adjustments |
- |
|
Net
Income Applicable To Common Shares |
691,226 |
|
Over
the past 34 years, KKR has invested in more than 185 transactions with a total
value of more than $435 billion. KKR's current private equity portfolio
includes over 60 portfolio companies with over $210 billion of annual
revenues and more than 900,000 employees. |
|
SUMMARY
|
|
|
Capsugel
is the world's leading provider of hard capsules and an innovator in drug
delivery systems for the pharmaceutical, OTC and health and nutrition
industries. |
|
RISK INFORMATION
|
|
|
DEBTS |
Controlled |
|
PAYMENTS |
Regular |
|
CASH
FLOW |
Normal |
|
SUGGESTED
CREDIT LINE |
USD
500 000 |
|
|
|
ENTERVIEW
|
|
|
NAME |
Yolanda
Sánchez |
|
POSITION |
Customer
Service |
|
COMMENTS |
She
confirmed address, activity and refused to confirm more data. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.61.65 |
|
|
1 |
Rs.96.54 |
|
Euro |
1 |
Rs.76.70 |
INFORMATION DETAILS
|
Analysis Done by
: |
RAS |
|
|
|
|
Report Prepared
by : |
NIT |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity. |
Limited with
full security |
|
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised. |
Credit not
recommended |
|
|
-- |
NB |
New Business |
-- |
|
This score serves as a reference to assess SC’s
credit risk and to set the amount of credit to be extended. It is calculated
from a composite of weighted scores obtained from each of the major sections of
this report. The assessed factors and their relative weights (as indicated
through %) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend (10%) Operational size
(10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or
its officials.